NCT00256555View on ClinicalTrials.gov

Growth Hormone Treatment Study in Children With Cystic Fibrosis

PHASE2/PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 29, 2000

Primary Completion Date

December 12, 2018

Study Completion Date

December 12, 2018

Conditions

Cystic Fibrosis

Interventions

DRUG

Nutropin AQ

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER